Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
Lancet
; 387(10033): 2117-2124, 2016 May 21.
Article
in En
| MEDLINE
| ID: mdl-26944026
Full text:
1
Database:
MEDLINE
Main subject:
Vasotocin
/
Calcium Channel Blockers
/
Nifedipine
/
Tocolytic Agents
/
Premature Birth
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Adult
/
Female
/
Humans
/
Newborn
/
Pregnancy
Country/Region as subject:
Europa
Language:
En
Year:
2016
Type:
Article